News

Buy Poly Medicure Ltd For Target Rs.1,060 - Anand Rathi Share and Stock Brokers Q3-FY23 Result Update Poly Medicure reported upbeat results in Q3FY22, Its revenues came in at Rs.2,848 Mn up by 23.7% YoY and 4% QoQ led by strong demand across segments. The company’s EBITDA/PAT came in at Rs.7,101 Mn/Rs.5,000 Mn up by 39%/45% YoY respectively. The company’s EBITDA margin in Q3FY23 came in at 24.9% vs 22.2% in Q3FY22 with a jump of 272bps YoY and 139 bps QoQ on account of moderating raw material prices and favourable product mix despite exports remaining m...
Buy Poly Medicure Ltd For Target Rs.1,060 - Anand Rathi Share and Stock Brokers
Buy Poly Medicure Ltd For Target Rs.1,060 - Anand Rathi Share and Stock Brokers
Source: Anand Rathi Share and Stock Brokers
8/03/2023 11:21:10 AM
Buy Poly Medicure Ltd For Target Rs.980 - Anand Rathi Share and Stock Brokers Q3-FY23 Result Update Poly Medicure reported upbeat results in Q3FY22, Its revenues came in at Rs.2,848 Mn up by 23.7% YoY and 4% QoQ led by strong demand across segments. The company’s EBITDA/PAT came in at Rs.7,101 Mn/Rs.5,000 Mn up by 39%/45% YoY respectively. The company’s EBITDA margin in Q3FY23 came in at 24.9% vs 22.2% in Q3FY22 with a jump of 272bps YoY and 139 bps QoQ on account of moderating raw material prices and favourable product mix despite exports remaining m...
Buy Poly Medicure Ltd For Target Rs.980 - Anand Rathi Share and Stock Brokers
Buy Poly Medicure Ltd For Target Rs.980 - Anand Rathi Share and Stock Brokers
Source: Anand Rathi Share and Stock Brokers Ltd
6/03/2023 12:03:26 PM
Hold Poly Medicure Ltd For Target Rs.980- ICICI Securities Strong print Poly Medicure’s (Polymed) Q2FY23 performance beats our estimates on all fronts. Revenue grew 23.0% YoY to Rs2.7bn (I-Sec: Rs2.6bn) led by strong demand across segments. EBITDA margin expanded 80bps YoY and 480bps QoQ to 23.5% which is expected to improve hereon. Adj. PAT was up 13.8% YoY to Rs435mn (ISec: Rs344mn). We like the company mainly due to its 1) strong presence in the fast-growing medical disposable segment, 2) industry tailwinds, 3) beneficiary of ‘China...
Hold Poly Medicure Ltd For Target Rs.980- ICICI Securities
Hold Poly Medicure Ltd For Target Rs.980- ICICI Securities
Source: ICICI Securities
14/11/2022 12:18:41 PM
Diwali Technical Muhurat Picks By Jainam Share Consultant Infosys INFY: Target - 1760, SL - 1190, Buy CMP : 50% at 1474 and 50% at 1330   Bajaj Finance BAJFINANCE: Target - 8510, SL - 6140, Buy CMP: 50% at 7272 and 50% at 6700   Navin Fluorine International Ltd NAVINFLUOR: Target - 5580, SL - 3900, Buy CMP: 50% at 4608 and 50% at 4300   TCI Express Ltd TCI: Target - 969, SL - 639, Buy CMP: 50% at 787 and 50% at 720   Poly Medicure Ltd POLYMED: Target - 1224, SL - 809 , Buy CM...
Diwali Technical Muhurat Picks By Jainam Share Consultant
Diwali Technical Muhurat Picks By Jainam Share Consultant
Source: Jainam Share Consultants Pvt Ltd
22/10/2022 3:45:00 PM
Buy Poly Medicure Ltd For Target Rs.849 - ICICI Securities Strong recovery in exports drives Q1 Poly Medicure’s (Polymed) Q1FY23 performance was a miss on the profitability front due to lower margins while revenues were on expected lines. Revenues grew 17.4% YoY to Rs2.5bn (I-Sec: Rs2.5bn) mainly due to strong recovery in exports. Domestic growth was impacted due to high base of covid. EBITDA margin stood at 18.7% against our estimates of 21.5% mainly due to one-off MTM losses. Also, raw material and freight costs have started softening; hen...
Buy Poly Medicure Ltd For Target Rs.849 - ICICI Securities
Buy Poly Medicure Ltd For Target Rs.849 - ICICI Securities
Source: ICICI Securities Ltd
19/09/2022 12:15:14 PM
Poly Medicure Q4 net profit up 3.50% at Rs 38.44 cr The company reported standalone net profit of Rs 38.44 crore for the quarter ended March 31, 2022 as compared to Rs 37.14 crore in the same period last year, registering a year-on-year growth of 3.50 per cent. Net revenue of the company rose substantially by 20.71 per cent at Rs 244.44 crore in January-March quarter of this fiscal as against Rs 202.51 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 25.39 per cent to Rs 187.59 crore fr...
Poly Medicure Q4 net profit up 3.50% at Rs 38.44 cr
Poly Medicure Q4 net profit up 3.50% at Rs 38.44 cr
Source: Dion Global Solutions Ltd
24/05/2022 4:42:53 PM